Full-Time
Territory Sales Executive
Confirmed live in the last 24 hours
AI-driven precision medicine through clinical and molecular data analysis
Senior, Expert
Remote in USA
- B.S. in life science, biology, business, or marketing
- 3+ years of direct account management experience in a molecular diagnostic setting
- 5+ years of experience working with major cancer centers and clinics, oncology GPO’s, large health systems, IHDN’s, and large oncology practices
- Demonstrated measurable revenue generation at either a diagnostic, pharmaceutical, or relevant biotechnology company
- Drive strategic business expansion/collaboration opportunities with major U.S. cancer centers and clinics
- Structure detailed strategic plans for gaining and retaining new and existing clients
- Maximize client-bill contracting opportunities
- Implement laboratory services agreements (LSA’s) with bill account institutions
- Collaborate and coordinate with all sales positions to ensure successful attainment of company goals and objectives
- Identify and develop partnering opportunities between prospective oncology clients and Tempus
- Promote and drive compliance with new web-based molecular information tools for all clients
- Continually analyze competitive landscape and environment within assigned accounts to determine trends and provide customer feedback to Tempus leadership
- Monitor performance of sales to ensure objectives are met
- Develop and implement a comprehensive business plan for the territory
- Work effectively with individuals across multiple departments throughout Tempus
- Embrace, embody, and represent the Tempus company culture at all times to external and internal constituents
Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.
Company Stage
Series G
Total Funding
$1.3B
Headquarters
Chicago, Illinois
Founded
2015